These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lysophosphatidic acid receptor-5 negatively regulates cellular responses in mouse fibroblast 3T3 cells. Dong Y; Hirane M; Araki M; Fukushima N; Tsujiuchi T Biochem Biophys Res Commun; 2014 Apr; 446(2):585-9. PubMed ID: 24632199 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines. Dong Y; Hirane M; Araki M; Fukushima N; Honoki K; Tsujiuchi T Mol Cell Biochem; 2014 Aug; 393(1-2):17-22. PubMed ID: 24676544 [TBL] [Abstract][Full Text] [Related]
6. Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells. Tanabe E; Kitayoshi M; Yoshikawa K; Shibata A; Honoki K; Fukushima N; Tsujiuchi T J Recept Signal Transduct Res; 2012 Dec; 32(6):328-34. PubMed ID: 23167620 [TBL] [Abstract][Full Text] [Related]
7. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892 [TBL] [Abstract][Full Text] [Related]
8. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na Jenkin KA; He P; Yun CC Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531 [TBL] [Abstract][Full Text] [Related]
9. Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5. Wang M; He P; Han Y; Dong L; Yun CC Cell Mol Gastroenterol Hepatol; 2021; 12(3):1073-1092. PubMed ID: 33975030 [TBL] [Abstract][Full Text] [Related]
10. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells. Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892 [TBL] [Abstract][Full Text] [Related]
15. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells. Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140 [TBL] [Abstract][Full Text] [Related]
16. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Kato K; Fukui R; Okabe K; Tanabe E; Kitayoshi M; Fukushima N; Tsujiuchi T Biochem Biophys Res Commun; 2012 Jan; 417(2):790-3. PubMed ID: 22197817 [TBL] [Abstract][Full Text] [Related]
17. LPA McConnell BB; Liang Z; Xu C; Han Y; Yun CC Am J Physiol Gastrointest Liver Physiol; 2024 Jun; 326(6):G631-G642. PubMed ID: 38593468 [TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms. Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789 [TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of endothelial cell migration by constitutively active LPA(1)-expressing tumor cells. Kitayoshi M; Kato K; Tanabe E; Yoshikawa K; Fukui R; Fukushima N; Tsujiuchi T Biochem Biophys Res Commun; 2012 Jun; 422(2):339-43. PubMed ID: 22580000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]